Effect of Smoking on Tuberculosis Treatment Failure: Meta-Analysis
DOI:
https://doi.org/10.26911/jepublichealth.2022.07.02.10Abstract
Background: Tuberculosis (TB) is an infectious disease that is the leading cause of health problems and death worldwide. Smoking is one of the factors that affect the outcome of TB treatment. This study aims to examine the effect of smoking on TB treatment failure.
Subjects and Method: Meta-analysis was carried out according to the PRISMA diagram using the PubMed, Science Direct, and Google Scholar databases. The keywords used ((tuberculosis OR TB) AND (smoking OR tobacco)) AND (impact OR treatment OR outcome OR effect). There were 9 studies with a cohort study design published in 2011-2021 that met the inclusion criteria. The analysis was performed with Revman 5.3.
Results: There were 9 articles consisting of 6 studies from Asia (Malaysia, Iran and Armenia), 1 study from North America (Mexico) and 1 study from South America (Brazil) which were included in this meta-analysis. Nine articles showed a significant effect of smoking on TB treatment failure (SMD= 1.88; 95% CI= 1.43 to 2.49; p< 0.001).
Conclusion: Smoking can increase tuberculosis treatment failure.
Keywords: tuberculosis, smoking, treatment, meta-analysis
Correspondence:
Victoria Sari. Faculty of Medicine, Universitas Sebelas Maret. Jl. Ir Sutami 36A, Surakarta 57126, Central Java. Email: victoriahusadani@gmail.com. Mobile: 081393539020.
References
Atif M, Sulaiman SAS, Shafie AA, Ali I, Asif M, Babar ZUD (2014). Treatment outcome of new smear positive pulmonary tuberculosis patients in Pe-nang, Malaysia. BMC Infect Dis. 14(1). doi: 10.1186/1471-2334-14-399.
Azeez A, Ndege J, Mutambayi R (2018). Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis. Int J Mycobacteriol, 7(4): 347–354. doi: 10.4103/IJMY.IJMY_140_18.
Balian DR, Davtyan K, Balian A, Grigoryan A, Hayrapetyan A, Davtyan H (2017). Tuberculosis treatment and Smoking, Armenia, 2014–2016. J Clin Tuberc Other Mycobact Dis. 8: 1–5. doi: 10.1016/j.jctube.2017.04.001.
Murti B (2018). Prinsip dan metode riset epidemiologi/ Bhisma Murti. Gajah Mada University Press. https://lib.ui.ac.id.
Bonacci RA, Cruz-Hervert LP, García-Gar-cía L, Reynales-Shigematsu LM, Ferreyra-Reyes L, Bobadilla-del-Valle M, Canizales-Quintero S, et al. (2013). Impact of cigarette smoking on rates and clinical prognosis of pulmonary tuberculosis in Southern Mexico. J Infect. 66(4): 303. doi: 10.1016/J.JINF.2012.09.005.
Burusie A, Enquesilassie F, Addissie A, Dessalegn B, Lamaro T (2020a). Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis. PLoS ONE, 15(9): 1–20. doi: 10.1371/journal.pone.0239333.
Burusie A, Enquesilassie F, Addissie A, Dessalegn B, Lamaro T (2020b). Effect of smoking on tuberculosis treatment outcomes: A systematic review and meta-analysis. PLOS ONE. 15(9): e0239333. doi: 10.1371/JOURNAL.PONE.0239333.
Cailleaux-Cezar M, Loredo C, e Silva JRL, Conde MB (2018). Impact of smoking on sputum culture conversion and pulmonary tuberculosis treatment outcomes in Brazil: a retrospective cohort study. J Bras Pneumol : Pu-blicacao Oficial Da Sociedade Brasi-leira de Pneumologia e Tisilogia, 44(2): 99–105. doi: 10.1590/S1806-37562017000000161.
Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, Kapata N, et al. (2021). Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts. IJID: Official Publication of the International Society for Infectious Diseases. 113 (1): S7–S12. doi: 10.1016/j.ijid.2021.02.107.
de Boer RN, Filho JBOS, Cobelens F, Ramalho DP, Miranda PFC, de Logo K, Oliveira H, et al. (2014). Delayed culture conversion due to cigarette smoking in active pulmonary tuberculosis patients. Tuberculosis, 94(1): 87–91. doi: 10.1016/j.tube.2013.10.005.
Feng Y, Kong Y, Barnes PF, Huang FF, Klucar P, Wang X, Samten B, et al. (2011). Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and Mycobacterium tuberculosis. Infect Immun. 79(1): 229–237. doi: 10.1128/IAI.0070910.
Gagnier JJ, Morgenstern H, Altman DG, Berlin J, Chang S, McCulloch P, Sun X, Moher D (2013). Consensus-based recommendations for investigating clinical heterogeneity in systematic reviews. BMC Med Res Methodol. 13(1). doi: 10.1186/1471-2288-13-106.
Kashyap RS, Nayak AR, Husain AA, She-khawat SD, Satav AR, Jain RK, Raje DV, et al. (2016). Impact of socio-economic status and living condition on latent tuberculosis diagnosis among the tribal population of Mel-ghat: A cohort study. Lung India: Official Organ of Indian Chest Society. 33(4): 372–380. doi: 10.4103/09702113.184868.
Khan AH, Sulaiman SAS, Hassali MA, Khan KU, Ming LC, Mateen O, Ullah MO (2020). Effect of smoking on treatment outcome among tuberculosis patients in Malaysia; A multi-center study. BMC Public Health, 20(1). doi: 10.1186/s12889-020-088-56-6.
Lee KK, Bing R, Kiang J, Bashir S, Spath N, Stelzle D, Mortimer K, et al. (2020). Adverse health effects associated with household air pollution: a systematic review, meta-analysis, and burden estimation study. Lancet Glob Health. 8(11): e1427–e1434. doi: 10.1016/S2214-109X(20)30343-0.
Liew SM, Khoo EM, Ho BK, Lee YK, Mimi O, Fazlina MY, Asmah R, et al. (2015). Tuberculosis in malaysia: Predictors of treatment outcomes in a national registry. IJTLD. 19(7), 764–771. doi: 10.5588/ijtld.14.0767.
Lugo-Villarino G, Troegeler A, Balboa L, Lastrucci C, Duval C, Mercier I, Bé-nard A, et al. (2018). The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M (IL-4) Macrophages in Response to Mycobacterium tuberculosis. Frontiers in Immunology. 9: 1123. doi: 10.3389/fimmu.2018.01123.
Masjedi MR, Hosseini M, Aryanpur M, Mortaz E, Tabarsi P, Soori H, Emami H, et al. (2017). The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis. ITJLD. 21(3): 351–356. doi: 10.5588/ijtld.16.0513.
Meira L, Chaves C, Araújo D, Almeida L, Boaventura R, Ramos A, Carvalho T, et al. (2019). Predictors and outcomes of disseminated tuberculosis in an intermediate burden setting. Pulmonology. 25(6): 320–327. doi: 10.1016/j.pulmoe.2018.11.001.
Mokti K, Isa ZM, Sharip J, Bakar SNA, Atil A, Hayati F, Rahim SSSA (2021). Predictors of delayed sputum smear conversion among pulmonary tuberculosis patients in Kota Kinabalu, Malaysia: A retrospective cohort study. Med. 100(31): e26841. doi: 10.1097/MD.0000000000026841.
Nguipdop-Djomo P, Rodrigues LC, Smith PG, Abubakar I, Mangtani P (2020). Drug misuse, tobacco smoking, alcohol and other social determinants of tuberculosis in UK-born adults in England: a community-based case-control study. Scientific Reports. 10(1). doi: 10.1038/s41598-020-626-67-8.
Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, Agbor VN, Bigna JJ (2019). Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. The Lancet Global Health. 7(4): e448–e460. doi: 10.1016/S2214109X(18)30487X.
Reitsma MB, Fullman N, Ng M, Salama JS, Abajobir A, Abate KH, Abbafati C, et al. (2017). Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. The Lancet. 389(10082): 1885–1906. doi: 10.1016/S0140-6736(17)30819-X.
Van Schayck OCP, Williams S, Barchilon V, Baxter N, Jawad M, Katsaounou PA, Kirenga BJ, et al. (2017). Treating tobacco dependence: guidance for primary care on life-saving interventions. Position statement of the IPCRG. NPJ Primary Care Respiratory Medicine. 27(1): 38. doi: 10.1038/s41533-017-0039-5.
Wang EY, Arrazola RA, Mathema B, Ahlu-walia IB, Mase SR (2020). The impact of smoking on tuberculosis treatment outcomes: A meta-analysis. IJTLD. 24(2): 170–175. doi: 10.5588/ijtld.19.0002.
WHO (2021). Global Tuberculosis Report 2021.https://www.who.int/publications/i/item/9789240037021.
